Prajwal C. Boddu

Hematology
5 Columbus Cir
New York, NY 10019

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications

A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers.

A Unifying Mechanism for Shared Splicing Aberrations in Splicing Factor Mutant Cancers.

Journal: bioRxiv : the preprint server for biology
Published: November 24, 2025

Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Feasibility, safety and outcomes of patients with newly diagnosed acute myeloid leukemia discharged 'early' after intensive induction.

Journal: Leukemia & lymphoma
Published: October 29, 2025

METTL3 promotes cell-cycle progression via activation of transcriptional elongation.

METTL3 promotes cell-cycle progression via activation of transcriptional elongation.

Journal: Molecular cell
Published: August 06, 2025

Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.

Transcription elongation defects link oncogenic SF3B1 mutations to targetable alterations in chromatin landscape.

Journal: Molecular cell
Published: March 28, 2023

Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape.

Transcription elongation defects link oncogenic splicing factor mutations to targetable alterations in chromatin landscape.

Journal: bioRxiv : the preprint server for biology
Published: March 09, 2023

The FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export.

The FANCI/FANCD2 complex links DNA damage response to R-loop regulation through SRSF1-mediated mRNA export.

Journal: Cell reports
Published: September 30, 2022

A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.

A phase 1 study to evaluate the safety, pharmacology, and feasibility of continuous infusion nelarabine in patients with relapsed and/or refractory lymphoid malignancies.

Journal: Cancer
Published: August 19, 2022

Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.

Generation of scalable cancer models by combining AAV-intron-trap, CRISPR/Cas9, and inducible Cre-recombinase.

Journal: Communications biology
Published: May 05, 2021

Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.

Distinct Immunophenotypes of T Cells in Bronchoalveolar Lavage Fluid From Leukemia Patients With Immune Checkpoint Inhibitors-Related Pulmonary Complications.

Journal: Frontiers in immunology
Published: August 01, 2020

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.

Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts.

Journal: The Lancet. Haematology
Published: April 25, 2020

Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod.

Successful treatment of cutaneous adult T-cell leukemia/lymphoma with imiquimod.

Journal: JAAD case reports
Published: November 12, 2019

Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.

Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia.

Journal: Expert review of anticancer therapy
Published: August 20, 2019
Showing 1-12 of 72

Last Updated: 09/26/2026